期刊文献+

乳腺癌中p27和c-erbB-2的表达及意义 被引量:2

Expression of p27 protein and c-erbB-2 protein in breast cancer and their clinical significance
下载PDF
导出
摘要 目的 探讨乳腺癌中 p2 7和c erbB 2表达情况和意义。 方法 用免疫组化S P法检测 4 0例乳腺癌中 p2 7和c erbB 2的表达。结果 正常乳腺组织c erbB 2表达阴性 ,癌组织中阳性率为 37 5 % (15 / 4 0 ) ,两者差异有显著性 (P <0 0 0 1)。 4 0例乳腺癌组织中 p2 7高表达率为 32 5 % (13/ 4 0 ) ,正常乳腺组织高表达为 80 % ,两者差异有显著性 (P <0 0 0 1)。p2 7高表达与癌组织分化、淋巴结转移和复发有关 (P <0 0 5 )。结论 基因p2 7和c erbB 2表达异常是乳腺癌产生的机制之一 ,与乳腺癌的发生及发展有关。p2 Purpose To study the relation between the expression of p27 and c-erbB-2 and breast cancer and to evaluate their clinical significances. Methods Inmmunohistochemical S-P method was used to analyze the expression of p27 and c-erbB-2 in the breast cancer. Results No expression of c-erbB-2 protein was observed in normal tissue. The positive rate of c-erbb-2 in breast cancer was 37.5%. There was significant difference between breast normal tissue and breast cancer (P<0.001). The rate of p27 overexpression in normal tissue and cancer were 80% and 32.5% respectively. There was significant difference between breast normal tissue and breast cancer (P<0.001), and it was related to the differentiation of breast cancer, lymph node metastasis and recurrence (P<0.05). Conclusions Lower expression of p27 and excessive expression of c-erbB-2 are mainly involved in breast carcinogenesis and p27 is associated with prognosis of breast cancer.
机构地区 解放军
出处 《临床与实验病理学杂志》 CAS CSCD 2004年第6期718-720,共3页 Chinese Journal of Clinical and Experimental Pathology
关键词 乳腺肿瘤 蛋白质P27 蛋白质c-erbB-2 免疫组织化学 breast neoplasms protein p27 protein c-erbB-2 immunohistochemistry
  • 相关文献

参考文献8

  • 1Masciullo A, Sgambato A, Pacilio C,et al. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer. Cancer Res, 1999,59(15): 3790~4.
  • 2Drissi H, Dennet H, Aslam F, et al. The cell cycle regulator p27 contributes to growth and differentiation of osteoblasts.CancerRes, 1999,59(15) :3705~11.
  • 3Sheer CJ. Cancer cell cycles. Science, 1996,274(5293): 1672-7.
  • 4李昊,张洪福,曹立宇.结直肠癌中cyclin D1和p27蛋白的表达及其意义[J].临床与实验病理学杂志,2003,19(3):273-276. 被引量:3
  • 5Esposito V, Baldi A, Luca AD, et al. Prognostic role of the cyclin-dependment kinase inhibitor gene p27 in non-small cell lung cancer. CancerRes, 1997,57(16) :3381~5.
  • 6边华琴,张洪福,周健,曹立宇.口腔鳞癌及癌前病变组织中p27、p53蛋白的表达[J].临床与实验病理学杂志,2003,19(2):181-184. 被引量:8
  • 7Chang JL,Tsao YP,Liu DW,et al.The expression of typeⅠgrowth factor receptors in the squamous neoplastic change of uterme cervix.GynecolOncol,1999,73(17):62~71.
  • 8冯晓莉,张学兵,万云霞,马建辉,孙耘田.肾细胞癌中c-erbB-2表达及其意义[J].临床与实验病理学杂志,2003,19(2):177-180. 被引量:2

二级参考文献39

  • 1[1]Youssef EM, Hasuma T, Morishima Y, et al. Overexpression of cyclin D1 in rat esophageal carcinogenesis model. Cancer Res, 1997,88:18~27.
  • 2[2]Weinstat-Saslow D, Merino MJ, Manrow RE, et al. Overexpression of cyclin D1 mRNA distinguishes invasive and in situ breast carcinomas from nonmalignant lesions. Nat Med, 1995,1:1257~60.
  • 3[3]Jiang W,Zhang JY, Kahn SM, et al. Altered expression of the cyclin D1 and retinoblastoma gene in human esophageal cancer. Proc Natl Acad Sci USA, 1993,90:9026~30.
  • 4[4]Donnellan R, Chetty R. Cyclin D1 and human neoplasia. J Clin Pathol Mol Part, 1998,51:1~7.
  • 5[5]Nishida N, Fukuda T, Koneda T, et al. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res, 1997,54:3107~10.
  • 6[6]Mate JL, Ariza A, Aracil C, et al. Cyclin D1 overexpression in non-small cell lung carcinoma:correlation with Ki-67 labelling index and poor cytoplasmic differentiation. J Pathol, 1996,180:395~9.
  • 7[7]Arber N, Hibshoosh H, Moss SF, et al. Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology, 1996,110:669~74.
  • 8[8]Polyak K, Kato J, Solomon M, et al. p27Kip1, a cyclin-CDK inhibitor: Links transforming growth factor-β and contact inhibition to the cell cycle arrest. Genes, 1994, 8:9~22.
  • 9[9]Piaparrone M, Yamanoto H, Yao Y, et al. Localization and expression of p27 in multistage colorectal carcinogenesis. Cancer Res, 1998,58:114~20.
  • 10[10]Surendra P, Lipman J, Goldman H, et al. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma. Cancer Res, 1997,58:1730~2.

共引文献10

同被引文献26

  • 1吴强.c-erbB-2(HER-2/neu)与乳腺癌[J].临床与实验病理学杂志,2005,21(1):6-9. 被引量:16
  • 2Nielsen T O,Hsu F D,Jensen K,et al.Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma[J].Clin Cancer Res,2004,10(16):5367-74.
  • 3Tsuda H,Takarabe T,Hasegawa T,et al.Myoepithelial differentiation in high-grade invasive ductal carcinomas with large central acellular zones[J].Hum Pathol,1999,30(10):1134-9.
  • 4Lakhani S R,Reis-Filho J S,Fulford L,et al.Prediction of BRCA1 status in patients with breast caner using estrogen receptor and basal phenotype[J].Clin Cancer Res,2005,11(14):5175-80.
  • 5Li D M,Sun H.TEP1 encoded by a candidate tumor suppressor locus,is a novel protein tyrosine phosphatase regulated by transforming growth factor beta[J].Cancer Res,1997,57(11):2124-9.
  • 6Dahia P L.PTEN,an unique tumor suppressor gene[J].Endocr Relat Cancer,2000,7(2):115-29.
  • 7Depowski P L,Rosenthal S I,Ross J S,et al.Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer[J].Mod Pathol,2001,14(7):672-6.
  • 8Bose S,Wang S I,Terry M B,et al.Allelic loss of chromosome 10q23 is associated with tumor progression in breast carcinomas[J].Oncogene,1998,17(1):123-7.
  • 9Marty B,Maire V,Gravier E,et al.Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells[J].Breast Cancer Res,2008,10(6):R101.
  • 10Polyak K,Kato J Y,Solomon M J,et al.p27 Kip1,a cyclin-Cdk inhibitor,links transforming growth factor-beta and contact inhibition to cell cycle arrest[J].Genes Dev,1994,8(1):9-22.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部